New ways to find antibiotics to fight resistant bacteria.
Innovative technologies to transform antibiotic discovery.
['FUNDING_OTHER'] · BROAD INSTITUTE, INC. · NIH-10670154
This study is working on new ways to find antibiotics that can fight tough bacteria like Klebsiella pneumoniae, and it's for anyone who is concerned about antibiotic resistance and wants better treatments in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BROAD INSTITUTE, INC. (nih funded) |
| Locations | 1 site (CAMBRIDGE, UNITED STATES) |
| Trial ID | NIH-10670154 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative technologies to discover new antibiotics that can effectively combat antibiotic-resistant bacteria, particularly Klebsiella pneumoniae and other Gram-negative pathogens. The project aims to create a collaborative center that combines expertise from various fields to address the urgent need for new antibiotics. By utilizing advanced methodologies and interdisciplinary approaches, the research seeks to overcome existing barriers in antibiotic discovery and establish a sustainable pipeline for future treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria, particularly those involving Klebsiella pneumoniae.
Not a fit: Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively treat infections caused by resistant bacteria, improving patient outcomes and saving lives.
How similar studies have performed: Other research initiatives have shown promise in developing new antibiotics and addressing antibiotic resistance, but this approach aims to introduce novel strategies that have not been extensively tested.
Where this research is happening
CAMBRIDGE, UNITED STATES
- BROAD INSTITUTE, INC. — CAMBRIDGE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HUNG, DEBORAH T — BROAD INSTITUTE, INC.
- Study coordinator: HUNG, DEBORAH T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: communicable disease control agent